Applied Clinical Trials-10-01-2008

Applied Clinical Trials

R&D In a Virtual World

October 01, 2008

A Closing Thought

0

0

A purely empirical approach to drug development may allow for evaluation of the overt factors that impact the balance of benefit and risk, but it will never uncover all potential scenarios for which companies are now being held accountable.

A Light at the End of the R&D Pipeline

October 01, 2008

News

0

0

After almost a decade of dim progress in drug development, R&D is finally making a come back, according to current data published in Parexel International's, "The U.S. Drug Approval Trends and Yearbook 2008/2009."